New York, New York (PRWEB) July 24, 2014
The federal judge overseeing thousands of GranuFlo lawsuits (http://www.injurybeacon.com/granuflo-dialysis/lawsuit/) in the U.S. District Court, District of Massachusetts, has issued a qualified protective order for plaintiff medical information covered by the federal Health Insurance Portability and Accountability Act. According to the July 16th Order, U.S. District Judge Douglas P. Woodlock has granted attorneys for Fresenius Medical Care the right to receive HIPAA- protected information. However, neither defense counsel nor their staff may discuss such information with plaintiffs’ treating physicians, and they may only disclose the information in accordance with case management orders. Finally, the Order stipulates that any health information must be returned or destroyed once the GranuFlo recall litigation concludes. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)
“Our Firm is representing a number of GanuFlo lawsuit plaintiffs in this proceeding, and we have been monitoring this matter closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free GranuFlo lawsuit evaluations to dialysis patients who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects within 72 hours of a dialysis treatment involving the use of GranuFlo or NaturaLyte dialysis drugs.
GranuFlo Recall Litigation
Court documents indicate that more than 1,940 lawsuits have been filed in the District of Massachusetts on behalf of dialysis patients who allegedly experienced serious cardiovascular events due to the administration of GranuFlo and NaturaLyte dialysis concentrates. All of the lawsuits pending in the federal litigation similarly allege that Fresenius failed to provide adequate warnings regarding the risks associated with GranuFlo and NaturaLyte, and that the company continued to aggressively market the products even once it became aware of those risks.
Both GranuFlo and NaturaLyte are manufactured by Fresenius Medical Care, and are administered to kidney failure patients to remove toxins from the blood during dialysis treatments. In March 2012, Fresenius issued an Urgent Product Notification for both products that warned of dosage issues that could cause dialysis patients to suffer serious and catastrophic heart side effects. The U.S. Food & Drug Administration (FDA) ultimately granted Class I recall status to the Urgent Product Notification, which indicates GranuFlo and NaturaLyte posed a risk of serious injury and death.
In addition to the cases pending in the District of Massachusetts, additional GranuFlo and NaturaLyte lawsuits have been consolidated on the state level in the Massachusetts’ Middlesex County Superior Court. Filings indicate that more than 3,900 claims are pending in that proceeding. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).
Individuals who were allegedly harmed by GranuFlo or NaturaLyte may be entitled to file their own GranuFlo lawsuit. To learn more about filing a GranuFlo recall claim, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP